I-131-Caerin 1.1 and I-131-Caerin 1.9 for the treatment of non-small-cell lung cancer

Liu, N; He, TT; Xiao, ZW; Du, J; Zhu, KK; Liu, XY; Chen, TS; Liu, WJ; Ni, GY; Liu, XS; Wang, TF; Quan, JT; Zhang, JH; Zhang, PP; Yuan, JW

Yuan, JW (通讯作者)，Guangdong Pharmaceut Univ, Affiliated Hosp 1, Clin Med Sch, Dept Nucl Med, Guangzhou, Guangdong, Peoples R China.;Zhang, PP (通讯作者)，First Peoples Hosp Foshan, Thorac & Abdominal Radiotherapy Dept, Foshan, Peoples R China.;Zhang, JH (通讯作者)，Gen Hosp Southern Theatre Command, Dept Nucl Med, Peoples Liberat Army China, Guangzhou, Peoples R China.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

ObjectiveTo investigate the effect of the I-131-labeled high-affinity peptides Caerin 1.1 and Caerin 1.9 for the treatment of A549 human NSCLC cells. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索